Summary:
Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder.
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Have a current episode of depression lasting at least 8 weeks but not more than 18 months
•
Have no more than partial response (<50% improvement) to ongoing treatment
•
Have not received a mood stabilizer within the past year or antipsychotic within the current episode
•
Not have Schizophrenia, Bipolar Disorder, Post-Traumatic Stress Disorder or Substance Abuse within the last 6 months
Qualified Participants May Receive:
Eligible participants will receive study related tests and procedures at no cost.
Compensation for time and travel.